Causes of death in polymyalgia rheumatica: A prospective longitudinal study of 315 cases and matched population controls

Scandinavian Journal of Rheumatology

Volumn 32, Issue 1, 2003, Pages 38-41

  Myklebust, Geirmund ^c   Wilsgaard, Tom ^a   Jacobsen, Bjarne Koster ^a   Gran, Jan Tore ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Aust Agder Hospital   (Norway)

Author keywords

Causes of death; Mortality; Polymyalgia rheumatica; Randomized trial

Indexed keywords

ADULT; AGED; ARTICLE; CANCER; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORWAY; POPULATION DYNAMICS; POPULATION RESEARCH; POPULATION RISK; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC POLYMYALGIA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STROKE; SURVIVAL;

AGED; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; FEMALE; HUMANS; MALE; NEOPLASMS; NORWAY; POLYMYALGIA RHEUMATICA; PROSPECTIVE STUDIES; RANDOM ALLOCATION; SURVIVAL RATE;

EID: 0037262731     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740310000382     Document Type: Article

References (26)

1. Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder South Norway: A prospective study 1987-94. J Rheumatol 1997;24:1739-43.
2. Hunder GG. Giant cell arteritis and polymyalgia rheumatica. Med Clin North Am 1997;81:195-219.
3. Gran JT, Myklebust G. Incidence and clinical characteristics of peripheral arthritis in polymyalgia rheumatica and temporal arteritis. Rheumatology 2000;39:283-7.
4. Falsetti P, Frediani B, Storri L, Bisogno S, Baldi F, Campanella V, et al. Evidence for synovitis in active polymyalgia rheumatica: Sonographic study in a large series of patients. J Rheumatol 2002;29:123-30.
5. Meliconi R, Pulsatelli L, Uguccioni M, Salvarani C, Macchioni P, Melchiorri C, et al. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Arthritis Rheum 1996;39:1199-207.
6. Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT. No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol. In press.
7. Haga HJ, Eide GE, Brun J, Johansen A, Langmark F. Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 1993;20:1335-9.
8. Säve-Söderbergh, Malmvall B-E, Andersson R, Bengtsson B-Å. Giant cell arteritis as a cause of death. JAMA 1986;255:493-6.
9. Nordborg E, Bengtsson BÅ. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. Br Med J 1989;299:549-50.
10. Mertens JC, et al. Polymyalgia rheumatica and temporal arteritis. A retrospective study of 111 patients. Clin Rheumatol 1995;14:650-5.
11. Schaufelberger C, Bengtsson B-Å, Andersson R. Epidemiology and mortality in 220 patients with polymyalgia rheumatica. Br J Rheumatol 1995;34:261-4.
12. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American college of rheumatology giant cell arteritis classification criteria cohort. Am J Med 1996;100:193-6.
13. González-Gay MA, Blanco R, Abraira V, García-Porrúa C, Ibáñez D, Rigueiro MT, et al. Giant cell artheritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol 1997;24:2171-6.
14. Uddhammar A, Eriksson AL, Nyström L, Stenling R, Rantapää-Dahlqvist S. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in Northern Sweden. J Rheumatol 2002;29:737-42.
15. Chuang T-Y, Hunder GG, Ilstrup DM, Kurland L. Polymyalgia rheumatica. A 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
16. Andersson R, Malmvall B-E, Bengtsson B-Å. Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Acta Med Scand 1986;220:361-4.
17. Boesen P, Sørensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. Arthritis Rheum 1987;30:294-9.
18. Bahlas S, Ramos-Remus C, Davis P. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis. J Rheumatol 1998;99-104.
19. Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology 2001;40:1238-42.
20. Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 1996;35:1161-8.
21. Bird HA, Esselinckx W, Dixon ASTJ, Mowat AG, Wood PHN. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38:434-9.
22. Hamrin B. Polymyalgia rheumatica. Acta Med Scand 1972;533(suppl):1-13.
23. Kvalvik AG, Jones MA, Symmons DPM. Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol 2000;29:29-37.
24. Riise T, Jacobsen BK, Gran JT, Haga H-J, Arnesen E. Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol 2001;20:123-7.
25. González-Gay MA, García-Porrúra C, Vázquez-Caruncho M, Dababneh A, Hajeer A, Ollier WER. The spectrum of polymyalgia rheumatica in Northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. J Rheumatol 1999;26:1326-32.
26. Duhaut P, Pinède L, Demolombe-Rague S, Loire R, Seydoux D, Ninet J, et al. Giant cell arteritis and cardiovascular cardiovascular risk factors. Arthritis Rheum 1998;41:1960-5.